6-Fluoro-7-methyl-1,4-dihydro-quinoxaline-2,3-dione | 1217304-00-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 6-Fluoro-7-methyl-1,4-dihydro-quinoxaline-2,3-dione
• 英文别名: 6-fluoro-7-methyl-1,4-dihydroquinoxaline-2,3-dione
• CAS: 1217304-00-1
• 化学式: C₉H₇FN₂O₂
• 分子量: 194.165
• InChiKey: RRGQQDFYSCCXER-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  58.2
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• HETEROCYCLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
  申请人：Borchardt Allen J.

  公开号：US20100120741A1

  公开（公告）日：2010-05-13

  The present invention relates to compounds and methods which may be useful as inhibitors of H 1 R and/or H 4 R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.

  本发明涉及化合物和方法，这些化合物和方法可能用作H1R和/或H4R的抑制剂，用于治疗或预防炎症性、自身免疫性、过敏性和眼部疾病。
• [EN] TRICYCLIC COMPOUNDS AS TEC KINASE INHIBITORS<br/>[FR] COMPOSÉS TRICYCLIQUES À TITRE D'INHIBITEURS DE KINASES TEC
  申请人：GLENMARK PHARMACEUTICALS SA

  公开号：WO2013153539A1

  公开（公告）日：2013-10-17

  The present invention is directed to tricyclic compounds of formula (I) as Tec kinase inhibitors, in particular ITK (interleukin-2 inducible tyrosine kinase) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders mediated by ITK.

  本发明涉及公式（I）的三环化合物，作为 Tec 激酶抑制剂，特别是 ITK（白细胞介素-2诱导酪氨酸激酶）抑制剂。本文还提供了制备所述化合物的方法，用于合成它们的中间体，它们的药物组合物，以及治疗或预防由 ITK 介导的疾病、症状和/或紊乱的方法。
• Urea Derivatives as Kinase Inhibitors
  申请人：Zhang Dawei

  公开号：US20120077851A1

  公开（公告）日：2012-03-29

  The present invention is directed to novel ureas, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R, R 1 to R 10 are defined herein.

  本发明涉及新型脲化合物及其衍生物、药用可接受的盐、溶剂化合物和水合物，这些化合物对蛋白激酶介导的疾病和病状具有治疗作用。本发明的化合物具有一般式(I)，其中R、R1到R10在此定义。